EMCDDA Home
  • EN
Search

Figure GPS-9. Last 12 months prevalence of ecstasy use among all adults (aged 15–64), young adults (aged 15–34) and youth (aged 15–24)

Part (ii) Males aged 15–24 in countries with high prevalence rates

 
 
CountryAll adults (15 to 64 yrs)Youth males (15 to 24 yrs)
Related links:
LT (2008)1.03.1
EE (2008)1.23.3
UK (E&W) (2011/12)1.44.3
PL (2010)1.56.7
CZ (2011)1.65.7
Statistical bulletin 2008: Figure GPS-9 part (ii)
Statistical bulletin 2009: Figure GPS-9 part (ii)
Statistical bulletin 2010: Figure GPS-9 part (ii)
Statistical bulletin 2011: Figure GPS-9 part (ii)
Statistical bulletin 2012: Figure GPS-9 part (ii)
See also Tables GPS-2 part i, GPS-2 part ii and GPS-2 part iii
See also 'General notes for interpreting data' on the Explanatory notes and help page

Notes:

Data are from the most recent national surveys available in each country.

The age range is from between 15 and 18 years to between 59 and 64 years. Variations in age ranges may slightly influence disparities between countries.

Czech Republic: 2011; 15–64 yrs n = 901; 15–34 yrs n = 361; 15–24 yrs n = 157

Estonia 2008; 15–64 yrs n = 1401; 15–34 yrs n = 545; 15–24 yrs n = 243

Lithuania: 2008; 15–64 yrs n = 4777; 15–34 yrs n = 2152; 15–24 n = 1165

Poland: 2010; 15–64 yrs n = 5782; 15–34 yrs n = 3201; 15–24 yrs n = 1736

UK (E&W): 2011/12; 16–59 yrs n = 26663; 16–34 yrs n = 9691; 16–24 yrs n = 3534

Sources:

Reitox national reports 2012, taken from population surveys, reports or scientific articles.

Country All adults (15 to 64 yrs) Youth males (15 to 24 yrs)
LT (2008) 1.0 3.1
EE (2008) 1.2 3.3
UK (E&W) (2011/12) 1.4 4.3
PL (2010) 1.5 6.7
CZ (2011) 1.6 5.7

gpsfig9b

 

About the EMCDDA

The European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) is the reference point on drugs and drug addiction information in Europe. Inaugurated in Lisbon in 1995, it is one of the EU's decentralised agencies. Read more >>

Contact us

EMCDDA
Praça Europa 1, Cais do Sodré
1249-289 Lisbon
Portugal
Tel. (351) 211 21 02 00
Fax (351) 218 13 17 11

More contact options >>

Page last updated: Tuesday, 30 April 2013